The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of genomic alterations of DNA repair genes in advanced bladder cancer (ABC).
 
Ming Yin
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Biocept; Bristol-Myers Squibb; Clovis Oncology; Dendreon; Driver, Inc; EMD Serono; Exelixis; Foundation Medicine; Genentech; Merck; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Siraj Mahamed Ali
Employment - Foundation Medicine; Foundation Medicine
Stock and Other Ownership Interests - Agios; Blueprint Medicines; Exelixis
Patents, Royalties, Other Intellectual Property - patents via FOundation Medicine; Patents via Seres Health on microbiome stuff in non neoplastic disease (I)
 
Joann Hsu
No Relationships to Disclose
 
Monali K. Vasekar
No Relationships to Disclose
 
Hamid Emamekhoo
Consulting or Advisory Role - Exelixis
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Monika Joshi
Research Funding - AstraZeneca (Inst)